Meropenem Trihydrate: Carbapenem Antibiotic for Broad-Spectrum Bacterial Research

Executive Summary: Meropenem trihydrate is a broad-spectrum carbapenem β-lactam antibiotic with low minimum inhibitory concentration (MIC90) values against diverse gram-negative and gram-positive bacterial pathogens, including Escherichia coli and Klebsiella pneumoniae (Dixon et al., 2025). Its antibacterial action is mediated by inhibition of penicillin-binding proteins (PBPs), resulting in cell wall disruption and bacterial lysis. The compound demonstrates enhanced efficacy at physiological pH (7.5) compared to acidic environments (pH 5.5) (Carbenicillin Sodium Review). Meropenem trihydrate is supplied by APExBIO as a water-soluble solid, with optimal stability at -20°C and short-term solution storage (APExBIO product page). Recent studies including LC-MS/MS metabolomics approaches have made meropenem central to resistance profiling and advanced infection research (Dixon et al., 2025).

Biological Rationale

Meropenem trihydrate is part of the carbapenem class of β-lactam antibiotics. These agents are recognized for their broad-spectrum activity, targeting both gram-negative and gram-positive bacteria as well as anaerobic pathogens (Dixon et al., 2025). The emergence of multidrug-resistant Enterobacterales, including K. pneumoniae and E. coli, underscores the importance of carbapenems in contemporary infectious disease research (Romidepsin.org). Meropenem trihydrate’s low MIC90 values enable precise modeling of resistance mechanisms and optimization of therapeutic strategies.

Mechanism of Action of Meropenem trihydrate

Meropenem trihydrate inhibits bacterial cell wall synthesis. It binds with high affinity to penicillin-binding proteins (PBPs), which are key enzymes in the transpeptidation step of peptidoglycan cross-linking. This binding disrupts cell wall integrity, causes osmotic instability, and leads to bacterial cell lysis and death. The mechanism is effective against β-lactamase-producing organisms due to the carbapenem’s stability against enzymatic hydrolysis (Prescission.com). Activity is enhanced at physiological pH; MIC values are significantly lower at pH 7.5 than at pH 5.5. Meropenem’s structure confers resistance to hydrolysis by most β-lactamases, including extended-spectrum β-lactamases (ESBLs).

Evidence & Benchmarks

• Meropenem trihydrate exhibits MIC90 ≤ 0.12–0.25 μg/mL against E. coli and K. pneumoniae at pH 7.5 (Dixon et al., 2025, https://doi.org/10.1007/s11306-025-02300-9).
• Carbapenemase-producing Enterobacterales (CPE) show distinct metabolomic profiles that can be rapidly characterized by LC-MS/MS, aiding resistance detection (Dixon et al., 2025, https://doi.org/10.1007/s11306-025-02300-9).
• Meropenem trihydrate demonstrates efficacy in animal models of acute necrotizing pancreatitis, reducing pancreatic infection and tissue necrosis (Apexbt.com product dossier, https://www.apexbt.com/meropenem-trihydrate.html).
• It exhibits water solubility ≥20.7 mg/mL at gentle warming (25–37°C) and DMSO solubility ≥49.2 mg/mL, but is insoluble in ethanol (APExBIO, https://www.apexbt.com/meropenem-trihydrate.html).
• Optimal storage at -20°C preserves compound stability; reconstituted solutions are recommended for short-term use only (APExBIO, https://www.apexbt.com/meropenem-trihydrate.html).

This article extends previous discussions on carbenicillin-disodium-salt.com by providing updated quantitative MIC data and integrating recent metabolomics findings; it also clarifies the mechanistic details absent from romidepsin.org and synthesizes workflow protocols described in meropenemtrihydrate.com.

Applications, Limits & Misconceptions

Meropenem trihydrate is used in research on bacterial infection treatment, antibiotic resistance, and acute necrotizing pancreatitis models. Its low MIC90 against both gram-negative and gram-positive bacteria makes it suitable for studies of resistance mechanisms and the molecular basis of β-lactamase activity. It is also a benchmark in metabolomic profiling of resistant phenotypes (Dixon et al., 2025).

Common Pitfalls or Misconceptions

• Meropenem trihydrate is not approved for therapeutic, diagnostic, or clinical use; it is strictly for scientific research.
• Antibacterial activity is pH-dependent; efficacy drops at acidic pH (5.5) relative to physiological pH (7.5).
• Some carbapenemases (e.g., OXA-48-like) may confer resistance even to carbapenems, limiting efficacy in certain strains (Dixon et al., 2025).
• Reconstituted solutions are unstable for long-term storage and should be prepared fresh for each experiment.
• Compound is insoluble in ethanol; use only water or DMSO as solvents.

Workflow Integration & Parameters

Meropenem trihydrate (SKU B1217) from APExBIO is supplied as a solid, enabling precise dosing. For aqueous applications, dissolve in water at ≥20.7 mg/mL with gentle warming (25–37°C). For DMSO-based protocols, dissolve at ≥49.2 mg/mL. Avoid ethanol due to insolubility. Store all forms at -20°C. Reconstituted solutions are intended for short-term use; discard if precipitate forms or after 24 hours at room temperature. MIC testing should be performed at pH 7.5 for optimal benchmarking. In vivo models, such as acute necrotizing pancreatitis in rats, have demonstrated decreased infection and tissue necrosis when meropenem is administered alone or with deferoxamine.

Conclusion & Outlook

Meropenem trihydrate remains a cornerstone for research on gram-negative and gram-positive bacterial infections, antibiotic resistance, and cell wall inhibition. Its broad-spectrum activity, water solubility, and validated benchmarks make it integral to advanced experimental workflows. Continued development of rapid resistance detection methods, such as metabolomics-based assays, will further enhance the utility of meropenem trihydrate in preclinical studies. APExBIO continues to provide validated, research-grade meropenem trihydrate to support scientific advancement (APExBIO product page).